This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Insurance Stock Q1 Earnings Due on Apr 30: CI, MMC & More
by Zacks Equity Research
Improved revenues might have driven earnings for insurance stocks in the first quarter of 2020.
LKQ Corp. (LKQ) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Lower vehicle sales amid a weakening consumer demand and soft economic conditions are expected to have hampered LKQ Corp's (LKQ) top line in Q1.
Is a Surprise Coming for Cigna (CI) This Earnings Season?
by Zacks Equity Research
Cigna (CI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Membership Growth Drive Cigna's (CI) Earnings in Q1?
by Zacks Equity Research
Cigna's (CI) Q1 earnings are likely to have been aided by revenue growth in various segments.
Zacks.com featured highlights include: Keysight Technologies, ResMed, Cigna and Jack Henry & Associates
by Zacks Equity Research
Zacks.com featured highlights include: Keysight Technologies, ResMed, Cigna and Jack Henry & Associates
The Zacks Analyst Blog Highlights: Limelight Networks, Chemed, Cigna, CURO Group and Huron Consulting Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Limelight Networks, Chemed, Cigna, CURO Group and Huron Consulting Group
Add These 4 GARP Stocks to Your Portfolio for Maximum Returns
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Will Dismal North American Market Hurt Ford's (F) Q1 Earnings?
by Zacks Equity Research
Declining sales in Ford's (F) North American segment likely to have hurt the company's Q1 bottom line.
Will Solid Model 3/Y Sales Drive Tesla's (TSLA) Q1 Earnings?
by Zacks Equity Research
Rise in Tesla's (TSLA) Model 3/Y deliveries likely to have fueled the company's earnings in the first quarter of 2020.
Cigna (CI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cigna (CI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Harley-Davidson (HOG) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
While Harley-Davidson's (HOG) efforts to bolster dealer networks is likely to have aided its revenues in Q1, high SG&A costs and rising competition remain concerns.
What's in the Offing for Cummins (CMI) This Earnings Season?
by Zacks Equity Research
Heightening coronavirus fears and elevated R&D expenses are likely to have dragged down Cummins' (CMI) margins in the first quarter.
5 Top Growth Stocks to Buy Ahead of Q1 Earnings This Month
by Nalak Das
Five growth stocks with a favorable Zacks Rank that are set to beat first-quarter earnings estimates this month.
What's in the Offing for Tesla (TSLA) This Earnings Season?
by Zacks Equity Research
While increasing Model 3 deliveries are likely to have aided Tesla's (TSLA) revenues in the first quarter, rising R&D and SG&A costs are concerns.
How Badly Will Coronavirus Hit Ford's (F) Q1 Earnings?
by Zacks Equity Research
Amid coronavirus outbreak and stay-at-home orders in multiple states, Ford (F) anticipates a net loss of $2 billion in the first quarter of 2020.
5 Healthcare Stocks Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Earnings results of healthcare sector are likely to reflect solid demand for its products and services from aging population and the growing incidence of COVID-19 illness.
O'Reilly (ORLY) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Elevated SG&A costs, along with weak demand of vehicles due to the coronavirus outbreak, are likely to have eroded O'Reilly's (ORLY) margins in Q1.
PACCAR (PCAR) Gearing Up for Q1 Earnings: What to Expect?
by Zacks Equity Research
Low orders for Class 8 trucks due to the outbreak of coronavirus are likely to have dented PACCAR's (PCAR) first-quarter 2020 revenues.
Q1 Earnings Scorecard and Analyst Reports for Netflix, Costco & Others
by Sheraz Mian
In addition to new research reports on 16 major stocks, including Netflix (NFLX), Costco (COST) and others, we also have real-time Q1 earnings scorecard today.
Cigna's (CI) New Solution to Boost Its Dental Care Services
by Zacks Equity Research
Cigna (CI) enhances its suite of dental care services with a virtual solution amid the pandemic. This is likely to help contain the virus spread.
What's in the Cards for UnitedHealth's (UNH) Q1 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings results to reflect gain from increase in revenues and the effect of share buyback.
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
7 Health Insurers Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.
Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks
by Tirthankar Chakraborty
Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.
Will Cigna (CI) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.